Björn Peters

Senior Executive & Entrepreneur in Life Sciences

[CDR-Life @CDRLifeBiotech]

@CDRLifeBiotech welcomes Nicole Onetto, MD, MSc as new Board Director! https://t.co/59D9bqzcmk

[Björn Peters @BjrnPet]

Looking forward to meeting potential partners and peers @Jefferies London!

[CDR-Life @CDRLifeBiotech]

We are attending 2022 @Jefferies London Healthcare Conference. Meet our #team at the conference…

[CDR-Life @CDRLifeBiotech]

Interesting read about pHLA complexes as promising targets for highly #cancer specific therapies: https://t.co/7B0jQli5Y7

[CDR-Life @CDRLifeBiotech]

Great to be nominated!

[CDR-Life @CDRLifeBiotech]

At the Next Generation Protein Therapeutics Summit today? Join our CSO @LeoBorrasLife who is talking about our M-gager technology in solid tumors later this afternoon...

[Björn Peters @BjrnPet]

@BiotechCH 👍🏼

[Björn Peters @BjrnPet]

Can’t wait to listen in and to attend #ASCO22 as the first of a series of upcoming in-person meetings in June! #BIO2022 #LSXWorld

[Biotech Hangout @BiotechCH]

Ready for #ASCO22? Join @bradloncar and Jacob Plieth of Evaluate this Friday to discuss the abstracts - less than a day after they come out!
https://t.co/yk157DzlGI

[Björn Peters @BjrnPet]

Impressive!

[Alex Ritter, PhD @AlexRitterPhD]

Small but mighty! This is a video of a killer T cell of the immune system destroying a monstrous ovarian cancer cell. I recently captured this data on a spinning disc confocal microscope.

[Björn Peters @BjrnPet]

Exciting moment for us at @CDRLifeBiotech! Looking forward to working with our new investors @Jeito_life, #RACapital and #OmegaFunds!

[CDR-Life @CDRLifeBiotech]

Big day today! Announcing closure of our $76m #SeriesA round led by @Jeito_life and #RACapital with participation from #OmegaFunds. https://t.co/uNEYSDjWDp

[CDR-Life @CDRLifeBiotech]

Presenting preclinical data today at #AACR22 on our antibody-based MAGE-A4 T cell engager in #solidtumors.
https://t.co/4TdCO5bBiT

[Björn Peters @BjrnPet]

Quite some firepower. Seems to become an exciting year…

[Travis Whitfill @twhitfill]

The top 17 pharma companies have $1.7 trillion in deal making capacity (cash + debt) in 2022. Let's see more M&A!

(data source: SVB Leerink)

[Dirk Reyn @DirkReyn]

A worthwhile read for all people trying to beat the odds in cancer - from an ex-collegae from Janssen
https://t.co/I18vbeRbOU via @CancerWorldESO

[Bertrand Delsuc @BertrandBio]

Multispefics are the 4th important wave of innovation in the biopharma industry, through the prism of $AMGN

[Björn Peters @BjrnPet]

10 million reasons why our scientists at @CDRLifeBiotech are passionate about developing #nextgenimmunotherapies! It’s #WorldCancerDay today. Support the community in this year’s effort to #CloseTheCareGap. https://t.co/ARYXZmbbjC

[Björn Peters @BjrnPet]

Good article on bispecific TCRs, a promising and developing space, @CDRLifeBiotech is part of…

[BioCentury @BioCentury]

At least nine TCR bispecifics are in clinical and preclinical development behind Immunocore's Kimmtrak, but none have advanced past Phase I: a BioCentury Data Byte https://t.co/GEOVGV31pF

[BioCentury @BioCentury]

At least nine TCR bispecifics are in clinical and preclinical development behind Immunocore's Kimmtrak, but none have advanced past Phase I: a BioCentury Data Byte https://t.co/GEOVGV31pF

[Björn Peters @BjrnPet]

@therealgianna Wow, I loved to wake up next to you and enjoy your beautiful smile ... gorgeous!

[Liam Donovan @LPDonovan]

The return of Terry Tate, office linebacker https://t.co/Q9yEYK84Z0

[Björn Peters @BjrnPet]

$HALO - incredible!!!